UNIGE document Scientific Article
previous document  unige:89789  next document
add to browser collection
Title

Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis
Authors
Girardin, François
Poncet, Antoine
Blondon, Marc
Rollason Gumprecht, Victoria
Vernaz-Hegi, Nathalie
Chalandon, Yves
Dayer, Pierre
Combescure, Christophe
Published in The Lancet Psychiatry. 2014, vol. 1, no. 1, p. 55-62
Abstract Long-term monitoring of white blood cell count is compulsory in patients taking clozapine, although the incidence of drug-induced agranulocytosis is lower than previously expected. The cost-effectiveness of this monitoring is unknown. We aimed to assess the cost-effectiveness of various strategies to monitor white blood cell count in adult patients with schizophrenia taking clozapine.
Identifiers
PMID: 26360402
Full text
Article (Published version) (1.6 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences
Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires
Research groups Epidémiologie clinique (115)
Groupe Desmeules Jules (pharmacologie/toxicologie) (567)
Citation
(ISO format) 		GIRARDIN, François et al. Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. In: The Lancet Psychiatry, 2014, vol. 1, n° 1, p. 55-62. doi: 10.1016/S2215-0366(14)70245-7 https://archive-ouverte.unige.ch/unige:89789

258 hits

0 download

Contact an author

Update request

Update

Deposited on : 2016-12-02

Export document
Format :
Citation style :